Dr Reddy's Q4 2023 preview: Here is what to expect from the drug maker

Dr Reddy Q4 results 2023 preview: Dr Reddy's Laboratories is likely to report a strong set of numbers for the quarter ending March 31, 2023 today, May 10. The pharmaceutical company is likely to report a 13 per cent year-on-year (YoY) increase in its consolidated revenue to Rs 6,174 crore against Rs 5,475 crore logged in Q4FY2023, according to Zee Business Research. The drug manufacturer's earnings before interest, taxes, depreciation, and amortisation (EBITDA) are expected to grow by 246 per cent to Rs 1,563 crore from Rs 451 registered in the year-ago period. The company is likely to report an 883 per cent increase in Profit after tax (PAT) to Rs 954 crore from Rs 97 crore a year ago.

The company's margins are expected to grow to 25 per cent from 8 per cent. Margins will get support due to falling raw material prices like APIs & organic solvents. Dr Reddy's US sales are expected to grow by 25 per cent to be around $25 - $33 crore. The company's operational performance as well as US sales and margins will be key factors to witness in the results.

Dr Reddy's Q4 results 2023 date

Dr Reddy's will release its Q4 earnings on May 10, Wednesday.

About Dr Reddy's

Dr Reddy's is a pharmaceutical company that manufactures and markets a wide range of pharmaceuticals overseas and in India. Dr Reddy's stock price has gained over 26 per cent in the last year (May 9, 2022). In comparison, the headline index Nifty 50 has rallied 11 per cent.

Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com